CClinicalTrials.gg
CompletedNCT06176417Updated Dec 19, 2023

Comparison Between Different Horizontal Ridge Augmentation Techniques

An interventional study of horizontal ridge augmentation by decompression technique. and horizontal ridge augmentation by ridge splitting technique using piezosurgery. in Atrophic Ridge, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-19.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 3 months after the study started (first participant enrolled Aug 2021, registered Dec 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Sixteen patients were selected from the Outpatient Clinic of the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University for replacement of missed single tooth / teeth in posterior atrophic mandible by dental implant.

Patients' grouping:

Patients were divided randomly into two equal uniform groups as follow:

Group I:

Eight implants were placed in patients of missing single tooth / teeth in posterior mandible with subsequent horizontal ridge augmentation by decompression technique.

Group II:

Eight implants were placed in patients of missing single tooth / teeth in posterior mandible with subsequent horizontal ridge augmentation by ridge splitting technique using piezosurgery.

All patients were evaluated clinically and radiographically at regular time interval immediately, 6 and 12 months after surgery.

02

Conditions studied

  • Atrophic Ridge

Browse trials for

03

In context

Atrophy

828 studies on the registry are indexed under Atrophy; 122 are open to participants now.

This study's enrollment of 16 is below the median of 34 across 603 interventional studies indexed under Atrophy.

Browse Atrophy studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patient's cooperation, motivation and good oral hygiene.
  • Patient medically free from systemic diseases that absolutely contraindicate implant surgery.
  • Moderately atrophic posterior mandible (horizontal alveolar dimension is not more than 4 mm at the crest), with minimum 10 mm vertical height.
  • Patients prepared to comply with the follow-up and maintenance programme.
  • Free from history of bruxism / parafunctional habits.

Exclusion criteria

Exclusion Criteria:

  • Patients with local pathological disease such as cyst, tumor at the planned surgical site.
  • Pregnant patients.
  • Heavy smoker patients.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    group 1

    Eight implants were placed in patients of missing single tooth / teeth in posterior mandible with subsequent horizontal ridge augmentation by decompression technique.

    Procedure: horizontal ridge augmentation by decompression technique.

  • Experimental
    group 2

    Eight implants were placed in patients of missing single tooth / teeth in posterior mandible with subsequent horizontal ridge augmentation by ridge splitting technique using piezosurgery.

    Procedure: horizontal ridge augmentation by ridge splitting technique using piezosurgery.

Interventions

  • Procedurehorizontal ridge augmentation by decompression technique.

    Instead of a cover screw, a 2-mm healing abutment was used after implant insertion

  • Procedurehorizontal ridge augmentation by ridge splitting technique using piezosurgery.

    horizontal ridge augmentation was done using piezosurgery tips and bone expanders

06

What researchers measure

Primary outcomes

  1. Alveolar ridge width

    The ridge width was measured on the cross section view at different time interval from the outer surface of the buccal bone to the outer surface of the lingual bone perpendicular to the line marking the long axis of the implant at implant platform. Changes in alveolar ridge width was measured by subtracting ridge width value after 6 and 12 months from immediate postoperative.

    Time frame: 12 months

07

Study locations

1 site
  • Sara Elmagraby
    Mansoura, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06176417
Lead sponsor
Mansoura University
Responsible party
Sara elmaghraby (assistant lecturer of oral and maxillofacial surgery, Mansoura University) — Principal investigator
First posted
Dec 19, 2023
Start date
Aug 26, 2021
Primary completion
Aug 26, 2023
Completion
Aug 26, 2023
Last update
Dec 19, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion